Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Vivo Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07432490
What this trial is testing

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Who this might be right for
Glut1 DeficiencyGLUT1DS1
Oregon Health and Science University 16
Testing effectiveness (Phase 2)Study completedNCT02036853
What this trial is testing

An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Adrian Lacy 20
Testing effectiveness (Phase 2)Study completedNCT03181399
What this trial is testing

Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)

Who this might be right for
GLUT1DS1EpilepsyGlut1 Deficiency Syndrome 1, Autosomal Recessive+4 more
University of Texas Southwestern Medical Center 45
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)WithdrawnNCT00971503
What this trial is testing

Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Moron 34
Not applicableWithdrawnNCT03202108
What this trial is testing

Evaluation of Krio in Children and Adults With Epilepsy

Who this might be right for
Ketogenic DietingEpilepsyGlucose Transporter Type 1 Deficiency Syndrome
Vitaflo International, Ltd
Testing effectiveness (Phase 2)Study completedNCT01819350
What this trial is testing

In Vivo Study of Sucrose and Liquid Oral Pediatric Medicines of Long-term Effect on Dental Biofilm pH

Who this might be right for
Dental Biofilm pH
Federal University of Paraíba 12
Not applicableTemporarily pausedNCT04137692
What this trial is testing

Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type 1 Deficiency SyndromeGLUT1DS1
Weill Medical College of Cornell University 12
Early research (Phase 1)Study completedNCT03041363
What this trial is testing

Treatment Development of Triheptanoin (G1D)

Who this might be right for
EpilepsyGLUT1DS1Glut1 Deficiency Syndrome 1, Autosomal Recessive+4 more
Juan Pascual 12
Not applicableNo Longer AvailableNCT02018302
What this trial is testing

Post Study Continuation of C7 for G1D

Who this might be right for
Glut1 Deficiency SyndromeGlucose Transporter Type 1 Deficiency Syndrome
Juan Pascual
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT02014883
What this trial is testing

Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS

Who this might be right for
Glut1 Deficiency Syndrome
Institut National de la Santé Et de la Recherche Médicale, France 20
Early research (Phase 1)Study completedNCT02018315
What this trial is testing

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

Who this might be right for
Glucose Transporter Type 1 Deficiency SyndromeGLUT1 Deficiency Syndrome
Juan Pascual 14
Not applicableNo Longer AvailableNCT02968953
What this trial is testing

Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome

Who this might be right for
Glucose Transporter 1 Deficiency Syndrome
Jerry Vockley, MD, PhD
Not applicableStudy completedNCT04399954
What this trial is testing

Evaluation of Ketoflo

Who this might be right for
Epilepsy IntractableGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting
Vitaflo International, Ltd 25
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT01993186
What this trial is testing

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 36
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Who this might be right for
Malaria,Falciparum
University of Oxford 34
Large-scale testing (Phase 3)Ended earlyNCT02960217
What this trial is testing

Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 44
Next Page